The market for digital dose inhalers for asthma and COPD will be worth $3.56 billion in 2024, according to a new prediction from Grand View Research.
Though connected inhalers are a new market, they've seen rapid growth in the last few years with interest from big pharma companies like AstraZeneca and Novartis, major device companies like Philips Respironics, as well as the newer, smaller...
Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI).
"Patients and physicians deserve better designed inhalers that are easier to use and help them successfully treat their chronic respiratory disease,” David Van Sickle, CEO of Propeller, said in a...
